Trimethoprim-sulfamethoxazole (TMP-SMX) is a potentiated sulfonamide antibiotic used in dogs for selected bacterial infections when the organism is susceptible and the expected benefit outweighs the drug’s distinctive adverse-effect risks. It combines two medicines that block different steps of bacterial folate metabolism. That combination can be bactericidal against organisms that might only be inhibited by either component alone.
Dog Medication Math Calculator
Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.
Dose information from your veterinarian
Optional liquid conversion
In dogs, TMP-SMX can be useful for urinary, respiratory, skin, prostate and other infections, but it is not a casual substitute for amoxicillin or cephalexin. Dogs are especially prone to some sulfonamide reactions, including dry eye, liver injury, blood-cell abnormalities, fever, joint pain and idiosyncratic hypersensitivity syndromes. Those risks make diagnosis, duration and monitoring important.
How the combination works
Sulfamethoxazole competes with para-aminobenzoic acid in bacterial folate synthesis, while trimethoprim blocks a later enzyme in the same pathway. Used together, the sequential blockade creates stronger antibacterial activity.
Merck Veterinary Manual describes potentiated sulfonamides as synergistic against many staphylococci, streptococci, E. coli and Proteus organisms. Activity is less reliable against some other bacteria and poor against Pseudomonas.
Which infections may be treated?
Veterinarians may use TMP-SMX for susceptible urinary tract infections, respiratory infections, prostatitis, some skin infections, selected gastrointestinal infections and certain opportunistic organisms.
Because resistance and adverse effects vary, culture and susceptibility testing are particularly useful in recurrent or complicated infections.
Urinary tract infections
TMP-sulfonamide combinations achieve useful urinary concentrations and can be effective against susceptible E. coli, Proteus and staphylococci. A simple first-time bladder infection may be treated empirically in some cases, but recurrent, kidney-associated or complicated infections deserve culture.
Diabetes, urinary stones, prostate disease and anatomic abnormalities can make recurrence more likely. Antibiotics alone do not correct those underlying problems.
Prostate infections
Trimethoprim has good tissue distribution and can cross the blood-prostate barrier, which makes potentiated sulfonamides potentially useful in bacterial prostatitis.
Merck notes that sulfonamide activity can be reduced in purulent material, so abscess formation or severe prostatic disease may require drainage, imaging or another strategy.
Respiratory infections
TMP-SMX can be used for susceptible bacterial respiratory disease. A cough, however, does not automatically mean a bacterial infection is present. Viral disease, chronic bronchitis, aspiration, fungal disease and heart disease can all produce respiratory signs.
Severe pneumonia should be assessed with imaging and, when possible, culture from an appropriate respiratory sample.
Skin infections
Potentiated sulfonamides have activity against some staphylococcal skin infections, but resistance is increasingly relevant. Recurrent pyoderma is a reason to look for allergy, endocrine disease, parasites or resistant organisms.
Repeated courses without addressing the underlying skin disorder can create resistance and ongoing relapse.
Trimethoprim-sulfamethoxazole dosage by weight: current canine reference
Merck currently lists trimethoprim-sulfamethoxazole in dogs at 30–45 mg/kg by mouth every 12 hours. That figure is based on the total amount of the combination, not one ingredient alone, and Merck classifies this as extra-label use in dogs.
| Reference item | Current canine guidance | Why it matters |
|---|---|---|
| TMP-SMX dose | 30–45 mg/kg PO every 12 hours | Total combination dose, not trimethoprim alone |
| Use status | Extra-label in dogs | Diagnosis and veterinary supervision are essential |
| Longer courses | Closer monitoring may be needed | Dogs are particularly susceptible to sulfonamide reactions, dry eye and blood-cell effects |
Source: Merck Veterinary Manual potentiated sulfonamide dosing table. A weight-based number does not decide whether this drug is appropriate for the infection or whether a safer first-line antibiotic exists.
Why sulfonamide adverse effects matter more in dogs
Dogs are particularly susceptible to idiosyncratic sulfonamide reactions. These are not simple dose-related stomach upset and may involve multiple organ systems.
Possible signs include fever, rash, facial swelling, joint pain, jaundice, unusual bruising, persistent vomiting, dry eye, lethargy and blood-cell changes. A dog that becomes systemically unwell during treatment should be assessed promptly.
Keratoconjunctivitis sicca: dry eye
One of the best-known canine sulfonamide complications is keratoconjunctivitis sicca (KCS), or dry eye. Sulfonamides can damage lacrimal gland function, and in some dogs the problem can be persistent even after the antibiotic is stopped.
Squinting, thick eye discharge, redness, rubbing at the eyes or a dull corneal surface should prompt veterinary examination and a tear-production test.
Why long courses deserve extra caution
Merck notes that chronic low-dose potentiated sulfonamide treatment can cause bone-marrow suppression and KCS in dogs. Risk is not limited to very high doses.
If a long course is necessary, the veterinarian may recommend a complete blood count, liver chemistry and eye monitoring depending on duration and patient risk.
Blood-cell abnormalities
Sulfonamides can cause anemia, low white blood cells or low platelets through bone-marrow suppression or immune-mediated reactions. Unusual bruising, pale gums, fever, weakness or recurrent infection should be reported.
A CBC helps distinguish a drug-related blood problem from the infection being treated.
Liver injury
Idiosyncratic hepatitis can occur with sulfonamide therapy. Appetite loss, vomiting, jaundice, dark urine or marked lethargy are not symptoms to “push through” until the course is complete.
Dogs with pre-existing liver disease may need another antibiotic or closer monitoring.
Joint pain and polyarthritis
Sulfonamide hypersensitivity can cause immune-mediated joint inflammation. A dog may become stiff, reluctant to walk, painful in several joints or suddenly less active.
This can be mistaken for orthopedic injury or worsening arthritis in an older dog. Timing relative to antibiotic treatment is important.
Fever and skin reactions
Drug fever, rash and other hypersensitivity signs can occur. Facial swelling, hives, breathing difficulty or collapse should be treated as urgent possible allergic reactions.
Less dramatic rash or fever still deserves a call because multi-system sulfonamide reactions can evolve.
Doberman Pinschers and possible increased susceptibility
Some sulfonamide hypersensitivity reactions have been reported more often in certain breeds, including Doberman Pinschers. Breed alone does not prove a reaction will occur, but it may make veterinarians more cautious about prolonged therapy.
Previous sulfonamide reaction is more important than breed. Tell the veterinarian if the dog has reacted to any “sulfa” medication before.
Kidney considerations
Sulfonamides and their metabolites are eliminated partly through the kidneys. Dehydration can increase concern for crystalluria with some sulfonamides, although modern combinations and veterinary dosing reduce this risk.
Fresh water should remain available. Dogs with kidney disease or poor hydration deserve individualized assessment.
Crystalluria and urine
Older sulfonamides were notorious for precipitating in urine. The risk varies by compound, urine pH and hydration. Signs such as blood in urine, straining or reduced urine production require veterinary attention.
Do not give alkalinizing or acidifying supplements without instructions; changing urine chemistry can affect other diseases and medications.
What if the dog is vomiting?
Repeated vomiting can indicate gastrointestinal intolerance, liver injury, hypersensitivity or the underlying infection. It also causes dehydration, which can make any renal concern more significant.
If a dose is vomited, do not automatically repeat it. Call the clinic if you cannot tell how much was absorbed.
What if a dose is missed?
Do not double the next dose automatically. Potentiated sulfonamides are often given once or twice daily depending on the product and indication.
Use the missed-dose guide for general principles and contact the clinic if several doses were missed during treatment of a serious infection.
What if an extra dose is given?
An extra dose may increase gastrointestinal upset and systemic exposure. A larger overdose or repeated double dosing deserves prompt veterinary advice.
Provide the exact tablet strength, number of tablets, dog’s weight, normal schedule and all other medications.
TMP-SMX and folate
The antibiotic targets bacterial folate metabolism more strongly than mammalian folate pathways, but prolonged therapy can still affect blood-cell production in susceptible animals.
Do not add folic acid or folinic acid automatically. Supplementation can be considered in selected situations but should not interfere with antimicrobial effectiveness or obscure another cause of cytopenia.
Drug interactions
Sulfonamides can interact with several drugs through protein binding, metabolism or additive adverse effects. The full medication list should be reviewed before treatment starts.
Tell the veterinarian about anticoagulants, seizure medicines, methotrexate-like drugs, diuretics and other chronic prescriptions.
TMP-SMX and warfarin-type anticoagulants
In species where vitamin K antagonist anticoagulants are used, sulfonamides can increase anticoagulant effect through metabolism and protein-binding interactions. Dogs receiving any antithrombotic medicine deserve careful medication review.
Unusual bleeding, bruising or black stool should be reported promptly regardless of the exact interaction mechanism.
TMP-SMX and seizure medicines
Some anticonvulsants are metabolized by liver pathways that can be influenced by antibiotics, and dogs with epilepsy may be more vulnerable to neurologic changes during systemic illness.
Do not stop anticonvulsants because an antibiotic is prescribed. The veterinarian can review the combination and monitor as needed.
Trimethoprim-sulfadiazine versus TMP-SMX
Veterinary products may contain trimethoprim combined with sulfadiazine, while human pharmacies commonly dispense trimethoprim-sulfamethoxazole. Both use the same sequential folate-blocking principle, but ratios, approved uses and formulations differ.
Do not substitute one product for another by tablet count alone.
Why the exact ratio matters
Commercial potentiated sulfonamides are formulated at specific trimethoprim-to-sulfonamide ratios. Microbiology susceptibility testing may use a different effective ratio at the infection site.
The practical implication is that dosing should follow veterinary references and the exact product, not an owner-generated calculation from the individual milligrams of each component.
Why Pseudomonas is a poor target
Pseudomonas is generally resistant to potentiated sulfonamides. A dog with chronic rod-shaped ear bacteria or a hospital-acquired gram-negative infection may therefore need a different antibiotic based on culture.
Continuing TMP-SMX against an intrinsically resistant organism only adds adverse-effect risk.
When treatment seems to fail
Failure may reflect resistance, wrong diagnosis, inadequate source control, poor adherence, abscess formation or an underlying disease that perpetuates infection.
Before extending the course or increasing dose, the veterinarian may repeat culture and reassess the infection site.
Antibiotic-associated gastrointestinal changes
Loose stool can occur during antibiotic therapy because intestinal microbial populations change. Mild transient symptoms may be manageable, but severe diarrhea, blood in stool or systemic illness deserves examination.
Do not assume a probiotic will protect against sulfonamide hypersensitivity or liver injury; those are different problems.
Pregnancy and breeding dogs
Folate-antagonist drugs raise special reproductive concerns. Pregnant, breeding or nursing dogs need individualized risk assessment and alternative options when appropriate.
Never use leftover TMP-SMX in a pregnant dog without veterinary direction.
Puppies
Young dogs may have different metabolism and sensitivity, and the indication should be clear before using a potentiated sulfonamide. Growth, hydration and concurrent disease all matter.
Veterinary guidance is especially important when prolonged treatment is being considered.
How long should therapy continue?
Duration depends on infection site. A simple bladder infection may need a much shorter course than prostatitis, deep skin infection or bone disease.
Longer is not automatically better. Antimicrobial stewardship aims to use enough treatment to cure the infection without unnecessary additional exposure.
Why culture after treatment may be useful
In recurrent urinary or prostate infection, a follow-up culture can help confirm that bacteria have been cleared rather than merely suppressed.
This is more informative than waiting for another relapse weeks later.
Questions to ask before starting
Ask whether culture supports TMP-SMX, how long treatment is expected to last, whether tear production or bloodwork should be monitored and which signs suggest an idiosyncratic sulfonamide reaction.
Tell the veterinarian about any previous sulfa allergy or dry-eye diagnosis.
Reliable references
The Merck Veterinary Manual sulfonamide review describes potentiated sulfonamide activity and important canine adverse effects. The Merck urinary-infection pharmacotherapy chapter discusses TMP-sulfa use and spectrum.
Why a normal-looking eye does not guarantee normal tear production
Early sulfonamide-associated KCS can be subtle. A dog may not yet have thick discharge or obvious corneal irritation even though tear production is declining. In longer courses or dogs with previous eye disease, a veterinarian may check tear production proactively rather than waiting for severe symptoms.
That is one reason prolonged TMP-SMX therapy should have a defined monitoring plan rather than becoming an open-ended refill.
Why a clear stop date matters
Potentiated sulfonamides should not drift into indefinite treatment without reassessment. A defined duration reduces unnecessary exposure to dry-eye, liver, blood-cell and hypersensitivity risks while still allowing enough time to treat the diagnosed infection properly.
When a refill changes manufacturer
Check the exact trimethoprim and sulfonamide strength on every refill. Human and veterinary products can differ in ratio and tablet size, so an old “number of tablets” instruction should not be carried over blindly when the product changes.
Bottom line
TMP-SMX is a useful, affordable antibiotic with broad activity against selected susceptible bacteria, but dogs have a distinctive risk of sulfonamide reactions involving the eyes, liver, blood cells, joints and other organs.
Use it for a clear infection, prefer culture in complicated cases, monitor long courses and contact the veterinarian promptly for dry-eye signs, fever, rash, joint pain, jaundice, unusual bruising or persistent vomiting.
DogMedsHub provides source-backed canine medication guidance and does not diagnose, prescribe or replace veterinary care.
Why eye monitoring can be proactive
Dry eye from sulfonamides can become uncomfortable before owners realize tear production has fallen substantially. In dogs receiving prolonged treatment or in breeds with existing ocular-surface disease, veterinarians may check a Schirmer tear test before or during therapy.
Do not wait for a thick green discharge to assume the eyes need attention. Redness, squinting or increased blinking can be earlier clues.
Why a previous “sulfa allergy” matters
A dog that previously developed fever, rash, liver injury, low blood counts or KCS during a sulfonamide course should not be casually rechallenged. Record the exact drug and reaction in the medical history.
Not every adverse event proves allergy, but a serious prior syndrome should influence future antibiotic selection.
When joint pain appears during treatment
Sudden stiffness affecting several limbs, reluctance to rise or fever during TMP-SMX therapy can represent immune-mediated polyarthritis rather than ordinary orthopedic pain. Giving an NSAID and continuing the antibiotic may mask the signal while the reaction progresses.
Contact the veterinarian for examination and appropriate testing if multi-joint pain develops.
Why long low-dose courses are not automatically safer
It can seem intuitive that a smaller dose for longer is gentler. With sulfonamides, prolonged exposure can still contribute to bone-marrow suppression and KCS. The dose and duration should match the infection rather than being reduced informally to avoid side effects.
If a standard regimen is not tolerated, the answer is usually reassessment or another antibiotic, not indefinite underdosing.
Hydration and urinary comfort
Normal access to water is important during therapy. A dog that stops drinking, vomits repeatedly or develops urinary straining deserves review because dehydration can worsen renal concerns and make sulfonamide metabolites more concentrated in urine.
Do not force excessive water or change urine pH with supplements unless the veterinarian recommends it.
Why treatment history helps future choices
Keep a record of which organism was cultured, whether TMP-SMX worked, how long it was used and whether any adverse effects occurred. That information can be valuable years later if another infection arises.
Antibiotic history helps the veterinarian distinguish a sensible reuse from a situation where resistance or prior intolerance makes another drug preferable.
